Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
CONCLUSIONS: Our clinical trials revealed phenotypic and genetic stability of the LAIV viruses recovered from the immunized volunteers. In addition, no vaccine virus was detected in the placebo groups indicating the lack of person-to-person transmission. LAIV TRIAL REGISTRATION at ClinicalTrials.gov: H7N3-NCT01511419; H5N2-NCT01719783; H2N2-NCT01982331.
PMID: 26432909 [PubMed - as supplied by publisher]
Source: Vaccine - Category: Allergy & Immunology Authors: Kiseleva I, Dubrovina I, Fedorova E, Larionova N, Isakova-Sivak I, Bazhenova E, Pisareva M, Kuznetsova V, Flores J, Rudenko L Tags: Vaccine Source Type: research
More News: Allergy & Immunology | Bird Flu | Bird Flu (H5N1 Avian Influenza) Vaccine | Clinical Trials | Flu Pandemic | Genetics | H2N2 | Influenza | Influenza Vaccine | Pandemics | Study | Vaccines